1Does being female provide a neuroprotective advantage following spinal cord injury?Jeffrey P.Datto, Jackie Yang, W.Dalton Dietrich, Damien D.Pearse1533-15362Ischemic long-term-potentiation (iLTP): perspectives to set the threshold of neural plasticity toward therapyMaximilian Lenz, Andreas Vlachos, Nicola Maggio1537-15393Delayed peripheral nerve repair: methods, including surgical ‘cross-bridging' to promote nerve regenerationTessa Gordon, Placheta Eva, Gregory H.Borschel1540-15444Neuroprotection and recovery from early-life adversity: considerations for environmental enrichmentAmanda C.Kentner1545-15475The emerging roles of transplanted radial glial cells in regenerating the central nervous systemRobin E.White, Denis S.Barry1548-15516Targeting α7 nicotinic acetylcholine receptors: a future potential for neuroprotection from traumatic brain injurySamuel S.Shin, C.Edward Dixon1552-15547Regulation of axonal remodeling following spinal cord injuryAnne Jacobi, Florence M.Bareyre1555-15578Handling iron in restorative neuroscienceLisa Junl Routhe, Torben Moos1558-15599Old dogs with new tricks: intra-axonal translation of nuclear proteinsJeffery L.Twiss, Tanuja T.Merianda1560-156210Schwann cell Miz without POZ: degeneration meets regenerationDavid Fuhrmann, Hans-Peter Els（a）sser1563-156411Exosomes in neurological disease, neuroprotection, repair and therapeutics: problems and perspectivesAnuradha Kalani, Neetu Tyagi1565-156712Superparamagnetic iron oxide nanoparticles: promote neuronal regenerative capacity?Jenni Neubert, Anja U.Br(a)uer1568-156913Role of myelin sheath energy metabolism in neurodegenerative diseasesSilvia Ravera, Isabella Panfoli1570-157114Effects of cancer therapy on hippocampus-related functionMiyoung Yang, Changjong Moon1572-157315Insights of the brain damage response using antibodies identifying surface antigens on neural stem cells and neuroblastsSilvia Santamaria, Jose A.Garcia-Sanz1574-157516Glypican 4 down-regulation in pluripotent stem cells as a potential strategy to improve differentiation and to impair tumorigenicity of cell transplantsRosanna Dono1576-157717Transforming growth factor β1-mediated anti-inflammation slows progression of midbrain dopaminergic neurodegeneration in Parkinson's disease?Bj(o)rn Spittau1578-158018Neurodegeneration and neuroinflammation: two processes, one targetPaulina Carriba, Joan X.Comella1581-158319Myelin morphology and axon pathology in demyelination during experimental autoimmune encephalomyelitisYoshio Bando1584-158520Gene therapy for Parkinson's disease: a decade of progress supported by posthumous contributions from volunteer subjectsRaymond T.Bartus1586-1588 